News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
19,351 Results
Type
Article (2032)
Company Profile (14)
Press Release (17305)
Section
Business (5900)
Career Advice (62)
Deals (780)
Drug Development (3257)
Employer Resources (3)
FDA (588)
Job Trends (759)
News (10229)
Policy (730)
Tag
Academia (279)
Alliances (1712)
ALS (4)
Alzheimer's disease (263)
Approvals (582)
Artificial intelligence (12)
Bankruptcy (6)
Best Places to Work (718)
Biotechnology (11)
Cancer (19)
Career advice (49)
CAR-T (4)
Cell therapy (7)
Clinical research (2478)
Collaboration (26)
Compensation (5)
COVID-19 (44)
C-suite (7)
Data (57)
Depression (15)
Diagnostics (68)
Earnings (1313)
Events (2719)
Executive appointments (23)
FDA (608)
Funding (19)
Gene therapy (6)
GLP-1 (24)
Government (75)
Healthcare (566)
Infectious disease (44)
Inflammatory bowel disease (9)
Interviews (12)
IPO (294)
Job creations (92)
Job search strategy (45)
Layoffs (23)
Legal (89)
Medical device (252)
Medtech (253)
Mergers & acquisitions (501)
Metabolic disorders (4)
Multiple sclerosis (11)
Neurodegenerative disease (9)
Neuropsychiatric disorders (5)
Neuroscience (352)
NextGen Class of 2024 (229)
Non-profit (217)
Northern California (56)
Opinion (8)
Pain (5)
Parkinson's disease (19)
People (2490)
Phase I (558)
Phase II (925)
Phase III (1135)
Pipeline (18)
Postmarket research (133)
Preclinical (370)
Psychedelics (8)
Radiopharmaceuticals (6)
Rare diseases (11)
Real estate (150)
Regulatory (614)
Research institute (234)
Resumes & cover letters (9)
Schizophrenia (24)
Series A (4)
Southern California (95)
Startups (144)
United States (625)
Vaccines (7)
Date
Today (10)
Last 7 days (19)
Last 30 days (129)
Last 365 days (1575)
2024 (1486)
2023 (1665)
2022 (1853)
2021 (2030)
2020 (1585)
2019 (1357)
2018 (1037)
2017 (1050)
2016 (1058)
2015 (1216)
2014 (870)
2013 (642)
2012 (614)
2011 (532)
2010 (457)
Location
Africa (16)
Arizona (5)
Asia (1327)
Australia (177)
California (169)
Canada (78)
China (11)
Colorado (5)
Connecticut (16)
Europe (3183)
Florida (37)
Illinois (36)
Indiana (11)
Japan (6)
Maryland (23)
Massachusetts (140)
Minnesota (7)
New Jersey (30)
New York (59)
North Carolina (11)
Northern California (56)
Ohio (6)
Pennsylvania (45)
South America (18)
Southern California (95)
Texas (11)
Utah (6)
Washington State (9)
19,351 Results for "amygdala neurosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
ABMRF Invests in Amygdala Neurosciences to Develop ANS-858 for Alcohol Use Disorder
Amygdala Neurosciences announced that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company’s IND-stage activities for ANS-858.
May 14, 2024
·
4 min read
Biotech Bay
Amygdala Neurosciences Awarded $2.0 million NIH Grant to Conduct IND Enabling Studies
Amygdala Neurosciences has been awarded a $2.0 million NIH grant to support the project titled “Investigational New Drug -enabling and Early-Stage Development of Selective, Reversible, Orally Bioavailable ALDH2 inhibitor ANS-00858 to Treat Alcohol Use Disorder.”
August 1, 2023
·
3 min read
Press Releases
Vistagen to Present at the 2024 Neuroscience Education Institute Congress
November 5, 2024
·
6 min read
Press Releases
Alto Neuroscience to Participate in Upcoming Investor Conferences
November 4, 2024
·
1 min read
Press Releases
ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference
November 26, 2024
·
1 min read
Press Releases
ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
November 14, 2024
·
13 min read
Business
Breakthrough in Brain–Computer Interface Technology: A New Era of Neural Decoding at the Society for Neuroscience Annual Meeting, Neuroscience 2024
October 7, 2024
·
4 min read
Genetown
Cerevance Presents at The Federation of European Neuroscience Societies (FENS) Forum 2024
Cerevance will deliver a poster presentation at the upcoming Federation of European Neuroscience Societies (FENS) Forum 2024, taking place in Vienna, Austria, from June 25 – 29, 2024.
June 18, 2024
·
2 min read
Business
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Evotec SE announced that the Company has reached important scientific progress within its neuroscience collaboration with Bristol Myers Squibb triggering a research payment of US$ 20 m to Evotec.
June 12, 2024
·
4 min read
Biotech Bay
Alto Neuroscience to Present at the Jefferies Global Healthcare Conference
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced that Company management will participate in the Jefferies Global Healthcare Conference, taking place June 5-6, 2024, in New York.
May 29, 2024
·
1 min read
1 of 1,936
Next
